Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASS™): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European Heart Journal, 26, 12, S. 1228-1234
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2005
- Event
-
Veröffentlichung
- (who)
-
Oxford University Press (OUP)
- (when)
-
2005
- Creator
-
Raake, Philip
Hinkel, Rabea
Kupatt, Christian
Brühl, Marie-Luise von
Beller, Sabrina
Andrees, Martin
Vicol, Calin
Boekstegers, Peter
- DOI
-
10.1093/eurheartj/ehi136
- URN
-
urn:nbn:de:bvb:384-opus4-965644
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Raake, Philip
- Hinkel, Rabea
- Kupatt, Christian
- Brühl, Marie-Luise von
- Beller, Sabrina
- Andrees, Martin
- Vicol, Calin
- Boekstegers, Peter
- Universität Augsburg
- Oxford University Press (OUP)
Time of origin
- 2005
Other Objects (12)
1081-61 Arterial retroperfusion by a percutaneous stent-based ventricle to coronary vein bypass (VVPASS™)
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Intraoperative model to flowmetry measurement from coronary-coronary saphenous vein graft bypass
1079-85 Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT™) in patients with multivessel disease undergoing coronary artery bypass surgery (ADVANTAGE)
Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT) in patients with multivessel coronary artery disease undergoing bypass surgery (ADVANTAGE): pilot phase [Abstract]
First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass
Amplifying effects of Relaxin by overexpression of its receptor
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
The clinical application of microincision vein harvesting of the great saphenous vein in coronary artery bypass grafting
1081-61 Arterial retroperfusion by a percutaneous stent-based ventricle to coronary vein bypass (VVPASS™)
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Intraoperative model to flowmetry measurement from coronary-coronary saphenous vein graft bypass
1079-85 Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT™) in patients with multivessel disease undergoing coronary artery bypass surgery (ADVANTAGE)
Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT) in patients with multivessel coronary artery disease undergoing bypass surgery (ADVANTAGE): pilot phase [Abstract]
First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass
Amplifying effects of Relaxin by overexpression of its receptor
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
The clinical application of microincision vein harvesting of the great saphenous vein in coronary artery bypass grafting
1081-61 Arterial retroperfusion by a percutaneous stent-based ventricle to coronary vein bypass (VVPASS™)
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Therapeutische Angiogenese bei chronischer Myokardischämie-Applikation von FGF-2 mittels selektiver druckregulierter Retroinfusion im tierexperimentellen Modell am Schwein
Intraoperative model to flowmetry measurement from coronary-coronary saphenous vein graft bypass
1079-85 Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT™) in patients with multivessel disease undergoing coronary artery bypass surgery (ADVANTAGE)
Adjunctive treatment with a stent-based ventricle to coronary artery bypass (VSTENT) in patients with multivessel coronary artery disease undergoing bypass surgery (ADVANTAGE): pilot phase [Abstract]
First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass
Amplifying effects of Relaxin by overexpression of its receptor
Hemopericardium Due to Idiopathic Coronary Artery Rupture Treated with Saphenous Vein Patch Plasty
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia